blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3496714

EP3496714 - DRUG COMPOSITIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.06.2024
Database last updated on 12.07.2024
FormerExamination is in progress
Status updated on  27.10.2023
FormerRequest for examination was made
Status updated on  17.05.2019
FormerThe international publication has been made
Status updated on  17.02.2018
Most recent event   Tooltip20.06.2024Application deemed to be withdrawnpublished on 24.07.2024 [2024/30]
Applicant(s)For all designated states
DMK Pharmaceuticals Corporation
11682 El Camino Real, Suite 300
San Diego, CA 92130 / US
[2023/47]
Former [2019/25]For all designated states
Adamis Pharmaceuticals Corporation
11682 El Camino Real, Suite 300
San Diego, CA 92130 / US
Inventor(s)01 / SUTHERLAND, David, Clayton
301 Garden Valley Loop
Little Rock, AR 72223 / US
02 / ZORN, James, Kyle
4588 Windstar Way
Lexington, KY 40515 / US
03 / CARLO, Dennis, J.
11682 El Camino Real
Suite 300
San Diego, CA 92130 / US
 [2019/25]
Representative(s)K&L Gates LLP
Friedrichstraße 110 A
10117 Berlin / DE
[N/P]
Former [2019/25]K&L Gates LLP
Markgrafenstrasse 42
10117 Berlin / DE
Application number, filing date17840369.711.08.2017
[2019/25]
WO2017US46599
Priority number, dateUS201662373871P11.08.2016         Original published format: US 201662373871 P
[2019/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018031935
Date:15.02.2018
Language:EN
[2018/07]
Type: A1 Application with search report 
No.:EP3496714
Date:19.06.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 15.02.2018 takes the place of the publication of the European patent application.
[2019/25]
Search report(s)International search report - published on:US15.02.2018
(Supplementary) European search report - dispatched on:EP19.03.2020
ClassificationIPC:A61K31/4439, A61K31/4184, A61K9/10, A61K9/14, A61K47/38, A61K45/06, C08L1/28, A61P1/04
[2020/17]
CPC:
A61K31/4184 (EP,KR,US); A61K9/0053 (KR); A61K31/4439 (EP,KR,US);
A61K45/06 (EP,US); A61K47/02 (KR); A61K47/10 (KR);
A61K47/38 (EP,KR,US); A61K9/0095 (KR); A61K9/08 (KR);
A61K9/10 (EP,US); A61K9/145 (EP,US); A61K9/1641 (US);
A61K9/1652 (US); A61P1/04 (EP,KR); A61P33/10 (KR);
A61K2300/00 (US); C01D5/14 (US); C01D7/10 (US);
C08B3/06 (US); C08L1/286 (EP,US) (-)
C-Set:
A61K31/4184, A61K2300/00 (US,EP);
A61K31/4439, A61K2300/00 (EP,US)
Former IPC [2019/25]A61K31/4439, A61K47/02, A61K47/18
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/25]
TitleGerman:ARZNEIMITTELZUSAMMENSETZUNGEN[2019/25]
English:DRUG COMPOSITIONS[2019/25]
French:COMPOSITIONS DE MÉDICAMENTS.[2019/25]
Entry into regional phase05.03.2019National basic fee paid 
05.03.2019Search fee paid 
05.03.2019Designation fee(s) paid 
05.03.2019Examination fee paid 
Examination procedure05.03.2019Examination requested  [2019/25]
07.10.2020Amendment by applicant (claims and/or description)
26.10.2023Despatch of a communication from the examining division (Time limit: M04)
06.03.2024Application deemed to be withdrawn, date of legal effect  [2024/30]
27.03.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2024/30]
Fees paidRenewal fee
05.03.2019Renewal fee patent year 03
27.08.2020Renewal fee patent year 04
27.08.2021Renewal fee patent year 05
29.08.2022Renewal fee patent year 06
28.08.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US6316481  (FREEHAUF KEITH [US]) [A] 1-14 * column 1, line 13 - line 21 * * column 1, line 46 - line 64 * * column 3, line 6 - line 15 *;
 [A]EP2144599  (FARNAM CO INC [US]) [A] 1-14* claims 22, 23, 27, 28, 47, 50 *
International search[Y]US2002065306  (PIPERS FRANK [US]) [Y] 19 * ; paragraphs [0012], [0045] *;
 [XY]US2004037869  (CLEVERLY DOUGLAS [NZ], et al) [X] 1-3, 6-8, 10, 12-16, 20-25, 28-29, 31-32 * ; paragraphs [0008], [0010]-[0011], [0029]-[0040], [0053], [0098], [0185]-[0186], [0189], [0192], [0202]; claims 2, 17, 29-30, 41, 47 * [Y] 4-5, 9, 11, 17-19, 26-27, 30, 33;
 [Y]US2005032719  (COTTRELL IAN [US], et al) [Y] 4-5, 9, 17-18, 26-27, 30 * ; paragraphs [0014], [0035], [0073] *;
 [Y]US2012046319  (MOHAR BARBARA [SI], et al) [Y] 11 * ; paragraph [0117] *;
 [Y]US2015057314  (PHILLIPS JEFFREY O [US]) [Y] 33* ; paragraphs [0090], [0102] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.